PNC Financial Services Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Sell |
|
|||||
|
2025
Q1 | $527K | Buy |
|
|||||
|
2024
Q4 | $556K | Sell |
|
|||||
|
2024
Q3 | $491K | Sell |
|
|||||
|
2024
Q2 | $458K | Sell |
|
|||||
|
2024
Q1 | $682K | Sell |
|
|||||
|
2023
Q4 | $642K | Buy |
|
|||||
|
2023
Q3 | $605K | Sell |
|
|||||
|
2023
Q2 | $764K | Sell |
|
|||||
|
2023
Q1 | $928K | Sell |
|
|||||
|
2022
Q4 | $915K | Sell |
|
|||||
|
2022
Q3 | $1.05M | Sell |
|
|||||
|
2022
Q2 | $932K | Buy |
|
|||||
|
2022
Q1 | $1.01M | Sell |
|
|||||
|
2021
Q4 | $940K | Buy |
|
|||||
|
2021
Q3 | $642K | Buy |
|
|||||
|
2021
Q2 | $680K | Buy |
|
|||||
|
2021
Q1 | $520K | Buy |
|
|||||
|
2020
Q4 | $222K | Buy |
|
|||||
|
2020
Q3 | $170K | Buy |
|
|||||
|
2020
Q2 | $155K | Buy |
|
|||||
|
2020
Q1 | $33K | Sell |
|
|||||
|
2019
Q4 | $67K | Sell |
|
|||||
|
2019
Q3 | $551K | Sell |
|
|||||
|
2019
Q2 | $3.06M | Sell |
|
|||||
|
2019
Q1 | $5.02M | Sell |
|
|||||
|
2018
Q4 | $6.33M | Sell |
|
|||||
|
2018
Q3 | $10.4M | Sell |
|
|||||
|
2018
Q2 | $12.5M | Sell |
|
|||||
|
2018
Q1 | $9.62M | Sell |
|
|||||
|
2017
Q4 | $8.45M | Sell |
|
|||||
|
2017
Q3 | $8.99M | Sell |
|
|||||
|
2017
Q2 | $10.7M | Buy |
|
|||||
|
2017
Q1 | $7.42M | Sell |
|
|||||
|
2016
Q4 | $6.62M | Buy |
|
|||||
|
2016
Q3 | $6.15M | Buy |
|
|||||
|
2016
Q2 | $468K | Sell |
|
|||||
|
2016
Q1 | $352K | Sell |
|
|||||
|
2015
Q4 | $1.42M | Sell |
|
|||||
|
2015
Q3 | $1.75M | Buy |
|
|||||
|
2015
Q2 | $1.14M | Buy |
|